SCN4A and channelopathy: The recent technological breakthroughs in omics technologies, medium-throughput patch-clamp procedures, 3D cultures, induced pluripotent stem cells, and gene-based therapies open exciting possibilities to fill these gaps for the eventual benefit of individuals with Nav1.4 channelopathies in the next years.